SCHEMBL6015145

SCHEMBL6015145

CC(C)c1ccc(C=O)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
TYR P14679 1/20 0.52
ALDH1A3 P47895 4/20 0.45
ALDH3A1 P30838 2/20 0.45
VCAM1 P19320 1/20 0.42
HSD17B10 Q99714 1/20 0.41
TSHR P16473 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
KDM4E B2RXH2 1/20 0.38
PTGS2 P35354 1/20 0.38
RAB9A P51151 1/20 0.38
CYP2A6 P11509 1/20 0.37
PTGER4 P35408 1/20 0.36
TTR P02766 1/20 0.36
TACR2 P21452 1/20 0.36
AOX1 Q06278 1/20 0.35
TRIM24 O15164 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27958720 0.85 ALDH1A1 (0.53) ALDH1A1TYRALDH1A3ALDH3A1VCAM1
SCHEMBL6015153 0.84 ALDH1A1 (0.57) ALDH1A1TYRALDH1A3ALDH3A1VCAM1
Ethane SCHEMBL2154115 0.82 ALDH1A1 (0.55) ALDH1A1TYRALDH1A3ALDH3A1VCAM1
SCHEMBL9231758 0.81 TYR (0.52) ALDH1A1TYRALDH1A3HSD17B10TSHR
SCHEMBL16957329 0.80 ALDH1A1 (0.39) ALDH1A1TYRTSHRLMNATP53
SCHEMBL16955280 0.80 LMNA (0.38) ALDH1A1TYRTSHRLMNATP53
SCHEMBL8031911 0.78 TYR (0.48) ALDH1A1TYRALDH1A3HSD17B10TSHR
SCHEMBL29818656 0.78 TYR (0.48) ALDH1A1TYRALDH1A3TSHRKDM4E
SCHEMBL3117644 0.78 TYR (0.48) ALDH1A1TYRALDH1A3TSHRKDM4E
SCHEMBL21749312 0.77 ALDH1A1 (0.53) ALDH1A1TYRALDH1A3ALDH3A1VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293729-B2 Compounds, pharmaceutical composition and methods relating thereto BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-10-23 US disclosed
US-20110166116-A1 NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-07 US disclosed
US-6984740-B2 Symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same MILLIKEN & COMPANY (US) 2006-01-10 US disclosed
EP-1425342-A4 NOVEL SYMMETRICAL SUBSTITUTED BENZALDEHYDE ALDITOL DERIVATIVES AND COMPOSITIONS AND ARTICLES CONTAINING SAME MILLIKEN & CO (US) 2005-01-05 EP disclosed
EP-1425342-A2 NOVEL SYMMETRICAL SUBSTITUTED BENZALDEHYDE ALDITOL DERIVATIVES AND COMPOSITIONS AND ARTICLES CONTAINING SAME Milliken & Company (US) 2004-06-09 EP disclosed
US-20030127631-A1 Novel symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same ANDERSON JOHN D (US) 2003-07-10 US disclosed
US-6547988-B2 Plastic additives which are useful as nucleating agents and which are especially useful for improving the optical properties of polymeric materials; also useful as gelling agents for water and organic solvents MILLIKEN & COMPANY 2003-04-15 US disclosed
US-20030008951-A1 Novel symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same MILLIKEN & COMPANY 2003-01-09 US disclosed
WO-2002077086-A2 NOVEL SYMMETRICAL SUBSTITUTED BENZALDEHYDE ALDITOL DERIVATIVES AND COMPOSITIONS AND ARTICLES CONTAINING SAME MILLIKEN & COMPANY (US) 2002-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008951-A1 Novel symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same ADH1C, ADH1A, ALDOA ALDH1A1 69/4885TYR 1955/4885ALDH1A3 55/4885
US-20110166116-A1 NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO MC2R, REN, CYP11B2 ALDH1A1 831/4885TYR 1759/4885ALDH1A3 1347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.